884
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Genuair® Usability Test: Results of a National Public Survey of the Elderly

, , , , , , , , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Konstantinos Kostikas, Theodoros I Vassilakopoulos, Nikos Tzanakis, Athanasios K Konstantinidis, Epameinondas N Kosmas, Spyros Papiris, Paschalis Steiropoulos, Effrosyni D Manali, Stylianos A Michaelides & Grigorios Daskos. (2020) A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 515-526.
Read now
Helgo Magnussen, Beatrix Fyrnys & Roland Greguletz. (2019) Genuair®/Pressair® Inhaler in COPD: The Patient Perspective. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 196-205.
Read now
Kwun Nok Mimi Man, Zhipeng Tian, David Chi-Leung Lam, Jennifer Man Fan Wan & Kian Cheng Tan-Un. (2018) Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1949-1963.
Read now
Pierachille Santus, Dejan Radovanovic, Andrea Cristiano, Vincenzo Valenti & Maurizio Rizzi. (2017) Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease. Drug Design, Development and Therapy 11, pages 3257-3271.
Read now
Marco Contoli, Paolo Solidoro, Fabiano Di Marco, Nicola Scichilone, Angelo Corsico, Fulvio Braido & Pierachille Santus. (2016) Effects of aclidinium on determinants of COPD severity: symptoms and quality of life. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3043-3050.
Read now

Articles from other publishers (7)

Sertan Bulut, Harun Karamanli & Pınar Akın Kabalak. (2021) Association of depression with improper use of inhaler devices by patients with obstructive disease. The Clinical Respiratory Journal 15:7, pages 721-727.
Crossref
Tiago Maricoto, Duarte Santos, Catarina Carvalho, Inês Teles, Jaime Correia-de-Sousa & Luís Taborda-Barata. (2020) Assessment of Poor Inhaler Technique in Older Patients with Asthma or COPD: A Predictive Tool for Clinical Risk and Inhaler Performance. Drugs & Aging 37:8, pages 605-616.
Crossref
Tiago Maricoto, Jaime Correia-de-Sousa & Luís Taborda-Barata. (2019) Inhaler technique education in elderly patients with asthma or COPD: impact on disease exacerbations—a protocol for a single-blinded randomised controlled trial. BMJ Open 9:1, pages e022685.
Crossref
A. A. Vizel & I. Yu. Vizel. (2018) 12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review. Medical Council:15, pages 116-122.
Crossref
Yasmin Kafaei Shirmanesh & Matthew D. Jones. (2018) Physical ability of people with rheumatoid arthritis and age-sex matched controls to use four commonly prescribed inhaler devices. Respiratory Medicine 135, pages 12-14.
Crossref
F. Blasi, G. W. Canonica & M. Miravitlles. (2017) Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?. Respiratory Research 18:1.
Crossref
Hiroyuki Ohbayashi, Sahori Kudo & Masatake Ishikawa. (2017) Inhaler Operability and Patient Satisfaction Regarding Genuair® and Respimat® Inhalers for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Study. Pulmonary Therapy 3:1, pages 173-185.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.